Top Markets
#1 Pleasing Gold Pleasing Gold +1,546.27%
#2 PulseChain PulseChain +55.72%
#3 Ontology Gas Ontology Gas +36.94%
#4 DogBull DogBull +36.89%
#5 BOOK OF MEME BOOK OF MEME +30.55%
#6 Neiro Neiro +21.85%
#7 Collect on Fanable Collect on Fanable +21.43%
#8 Nockchain Nockchain +19.56%
#9 Pump.fun Pump.fun +19.14%
#10 Unit Pump Unit Pump +19.14%
Coin of the day
Pleasing Gold Pleasing Gold
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Classifica tra le azioni #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Prezzo delle azioni
$0.12164306
Ultima sincronizzazione: 2024-11-11
Capitalizzazione di mercato
$38.53M
Variazione (1 giorno)
-4.14%
Variazione (1 anno)
0.00%
Paese
AU
Scambia PharmAust Limited (PAA)

Categoria

Healthcare
Margine operativo per PharmAust Limited (PAA)
Margine operativo al August 2026 TTM: 0.00%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di PharmAust Limited, il margine operativo attuale (TTM) è 0.00%. Alla fine del 2024, il margine operativo era 0.00%.
Storico del margine operativo per PharmAust Limited da 2001 a 2026
Margine operativo alla fine di ogni anno
Anno Margine Operativo Cambia
2026 (TTM) 0.00% 0.00%
2025 0.00% 0.00%
2024 0.00% -100.00%
2023 -128.28% 57.79%
2022 -81.30% -37.62%
2021 -130.34% 91.87%
2020 -67.93% 94.09%
2019 -35.00% -54.92%
2018 -77.64% 96.01%
2017 -39.61% -41.89%
2016 -68.16% -17.97%
2015 -83.09% 16.52%
2014 -71.31% 97.92%
2013 -36.03% -86.21%
2012 -261.31% -30.50%
2011 -375.99% 873.56%
2010 -38.62% 8.94%
2009 -35.45% -61.38%
2008 -91.79% 3.86%
2007 -88.38% 62.76%
2006 -54.30% -4.05%
2005 -56.59% -82.53%
2004 -323.98% -88.85%
2003 -2,904.41% 428.71%
2002 -549.34% 0.00%
2001 0.00% 0.00%
Margine operativo per aziende simili o concorrenti
Azienda Margine Operativo Differenza del margine operativo Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.